|
|
Volumn 10, Issue 5, 2011, Pages 338-339
|
|
Anticancer drugs: SRC hits the mark
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
LAPATINIB;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
TRASTUZUMAB;
BREAST CANCER;
CANCER RESISTANCE;
CANCER SURVIVAL;
CONCENTRATION RESPONSE;
DOWN REGULATION;
DRUG EFFICACY;
DRUG TARGETING;
ERBB2 GENE;
GENE OVEREXPRESSION;
HER2 GENE;
HUMAN;
NONHUMAN;
NOTE;
ONCOGENE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
SRC GENE;
TREATMENT RESPONSE;
|
|
EID: 79955624801
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3451 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
